World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
39857
World Ranking
5823
National Ranking
3124

Bruce D. Minsky publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bruce D. Minsky sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 591 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bruce D. Minsky D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce D. Minsky sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bruce D. Minsky is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their primary research falls within the broad field of Medicine, with significant publications in Surgery, Pulmonary and Respiratory Medicine, Oncology, Economics and Econometrics, and Radiology, Nuclear Medicine and Imaging.

The scientist's main research topics span several areas related to cancer management and treatment. These topics include:

  • Gastric Cancer Management and Outcomes
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Surgical Treatments
  • Pancreatic and Hepatic Oncology Research
  • Metastasis and carcinoma case studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gastrointestinal Tumor Research and Treatment

Minsky's scholarly output includes numerous articles in prominent journals. Frequent publication venues consist of:

  • International Journal of Radiation Oncology*Biology*Physics
  • Annals of Surgical Oncology
  • Journal of Clinical Oncology
  • Clinical Colorectal Cancer
  • Radiotherapy and Oncology

Some of the recent papers involving or related to their research are:

  • International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer, 2021, Nature Reviews Clinical Oncology
  • The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy, 2020, Frontiers in Oncology
  • Outcome measures in multimodal rectal cancer trials, 2020, The Lancet Oncology
  • A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology, 2020, Annals of Surgical Oncology
  • NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience, 2022, Clinical and Translational Radiation Oncology

Bruce D. Minsky has collaborated with several frequent co-authors, including:

  • Prajnan Das
  • Ethan B. Ludmir
  • Cullen M. Taniguchi
  • Emma B. Holliday
  • Eugene J. Koay

Best Publications

  • INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

    Bruce D. Minsky;Thomas F. Pajak;Robert J. Ginsberg;Thomas M. Pisansky

  • Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

    David P. Kelsen;Robert Ginsberg;Thomas F. Pajak;Daniel G. Sheahan

  • Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline

    Christopher E. Desch;Al B. Benson;Mark R. Somerfield;Patrick J. Flynn

  • Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

    David P. Kelsen;Katryn A. Winter;Leonard L. Gunderson;Joanne Mortimer

  • Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum.

    Klaas Havenga;Warren E. Enker;Warren E. Enker;Katherine McDermott;Alfred M. Cohen

  • Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

    Jose G. Guillem;David B. Chessin;Alfred M. Cohen;Jinru Shia

  • The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.

    Fabio Maria Vecchio;Vincenzo Valentini;Bruce D. Minsky;Gilbert D.A. Padula

  • Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients.

    Spiros P Hiotis;Sharon M Weber;Alfred M Cohen;Bruce D Minsky

  • Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

    Vincenzo Valentini;Ruud G.P.M. Van Stiphout;Guido Lammering;Maria Antonietta Gambacorta

  • Long-Term Results of Local Excision for Rectal Cancer

    Philip B. Paty;Garrett M. Nash;Paul Baron;Maureen Zakowski

  • Neuroendocrine carcinomas of the colon and rectum.

    P. E. Bernick;D. S. Klimstra;J. Shia;B. Minsky

  • Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial

    Robert J. Downey;Tim Akhurst;David Ilson;Robert Ginsberg

  • Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.

    Warren E. Enker;Nipun Merchant;Alfred M. Cohen;Nicole M. Lanouette

  • Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

    Jeffrey A. Meyerhardt;Pamela B. Mangu;Patrick J. Flynn;Larissa Korde

  • Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.

    J. Milburn Jessup;J. Milburn Jessup;M. Andrew Stewart;Frederick L. Greene;Bruce D. Minsky

  • Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.

    Bruce D. Minsky;Alfred M. Cohen;Nancy Kemeny;Warren E. Enker

  • Molecular biomarkers for the evaluation of colorectal cancer: Guideline from The American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology

    Antonia R. Sepulveda;Antonia R. Sepulveda;Stanley R. Hamilton;Carmen J. Allegra;Wayne Grody

  • Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy

    Leyo Ruo;Satish Tickoo;David S. Klimstra;Bruce D. Minsky

  • Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

    Carlos Fernández-Martos;X. Garcia-Albeniz;C. Pericay;J. Maurel

  • Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer

    Alison Grann;Bruce D. Minsky;Alfred M. Cohen;Leonard Saltz

Frequent Co-Authors

Jose G. Guillem
Jose G. Guillem University of North Carolina at Chapel Hill
Alfred M. Cohen
Alfred M. Cohen Cancer Prevention Pharmaceuticals (United States)
Philip B. Paty
Philip B. Paty Memorial Sloan Kettering Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
W. Douglas Wong
W. Douglas Wong Memorial Sloan Kettering Cancer Center
David P. Kelsen
David P. Kelsen Memorial Sloan Kettering Cancer Center
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
Sunil Krishnan
Sunil Krishnan The University of Texas MD Anderson Cancer Center
Martin R. Weiser
Martin R. Weiser Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options in medicine doesn’t always mean attending traditional medical school. Today, a variety of online degrees offer flexible and affordable entry points into healthcare. For those seeking advanced practice roles, the cheapest online bsn to dnp programs are a cost-effective path for registered nurses aiming to achieve the highest level of nursing education.

In pharmacy, accelerated options are available, such as the 3-year online pharmd programs. These allow students to earn a Doctor of Pharmacy degree on a faster timeline while maintaining flexibility.

Not all health careers require patient-facing roles. A strong demand exists for professionals skilled in managing electronic health data. Many students are choosing online schools for health information management, which lead to jobs in healthcare data integrity, privacy, and administration.

For quick entry into healthcare, consider administrative careers. The cheapest medical billing and coding online courses provide essential skills to start working in medical billing, coding, and insurance processing in under a year.

Best Scientists Citing Bruce D. Minsky

Trending Scientists

Recently Published Articles